Kappa Bioscience

Kappa-Bioscience.jpg

Kappa Bioscience® AS is a leading manufacturer of pure, all-bioactive vitamin K2 MK-7 under the K2VITAL® brand, the reference standard for the United States Pharmacopeia - used globally as the benchmark for vitamin K2 analysis and cis/trans purity assessments. Founded and headquartered in Oslo, Norway, the company recently became part of Balchem Corporation, a US-based global specialty ingredients company focused on Nutrition and Health.

By providing 99.7% all-trans vitamin K2 MK-7 – identical to the K2 molecule found in nature and fully bioactive - with unmatched purity and stability, patented processes and innovative technologies, Kappa Bioscience® aims to bring the best possible health benefits to consumers around the world supporting bone and cardiovascular health, healthy ageing and immune health among others.

Kappa Bioscience® provides a full assortment of over 150 vitamin K2 based formulations, backed by consumer research and designed to meet key healthcare needs while shortening development cycles from months to weeks – or even days. K2VITAL® can be used in all relevant dosage forms from tablets to soft-gels, powders to liquids, and even gummies and oral sprays.  K2VITAL® DELTA is a proprietary microencapsulated solution for complete stability in any environment and ideal for pairing with other ingredients, such as vitamin D, calcium, magnesium, omega-3, probiotics and botanicals.

Kappa Bioscience® believes in better health for all, which can only be achieved through close and open collaboration. The company works with partner network of health & nutrition brands, contract manufacturing organisations and distributors around the globe, to help the health and nutrition industry turn a corner, without cutting corners.

Through Kappa Solutions, the company offers a completely integrated range of organic chemistry and analytical services, cGMP certified labs and unmatched knowledge of vitamin K2.

From turn-key solutions, product launches and growth strategies, to support with label claims, research and marketing initiatives, Kappa Bioscience® believes in doing it right. That means developing products and services that set new standards of excellence, made with integrity, and through close collaboration.

Latest Content

Vitamin K2 MK-7: A stability challenge, a market study

Vitamin K2 MK-7: A stability challenge, a market study

Paid for and content provided by Kappa Bioscience

Demand for vitamin K2 has increased rapidly over the past decade as awareness of its role in bone and cardiovascular health has spread. However, studies run by Kappa Bioscience show many K2 products contain lower-than-claimed levels of the vitamin, a...

Related Resources

New Market Study Reveals K2 Stability Problem

New Market Study Reveals K2 Stability Problem

Content provided by Kappa Bioscience

Research Study

Half of all vitamin K2 products tested in a 2016 Market Study missed label claim by 50% or more. One-in-five demonstrated no measurable K2 content (zero). These products failed in both...